Effect of inhaled corticosteroid on an immunoreactive thymus and activation-regulated chemokine expression in the bronchial biopsies from asthmatics

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 60, Issue 3, 2005, Pages 317-322

  Hoshino, Makoto ^a   Nakagawa, T ^a   Sano, Y ^b   Hirai, K ^c  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Doai Memorial Hospital   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Airway inflammation; Bronchial asthma; Budesonide; IL 4 receptor alpha; Th2 cytokine; Thymus and activation regulated chemokine

Indexed keywords

BUDESONIDE; CORTICOSTEROID; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; PLACEBO; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADULT; ARTICLE; ASTHMA; BRONCHUS BIOPSY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INFLAMMATORY INFILTRATE; MALE; PRIORITY JOURNAL; SKIN TEST; STATISTICAL ANALYSIS; TH2 CELL;

ADMINISTRATION, INHALATION; ADULT; ANTIGENS, CD3; ASTHMA; BIOPSY; BRONCHI; BRONCHODILATOR AGENTS; BUDESONIDE; CD4 LYMPHOCYTE COUNT; CHEMOKINES, CC; DOUBLE-BLIND METHOD; EOSINOPHILS; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; T-LYMPHOCYTES;

EID: 14344258968     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2005.00694.x     Document Type: Article

References (29)

1. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma: from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1726-1745.
2. Larche M, Robinson DS, Kay AB. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 2003;111:450-463.
3. Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor4. J Biol Chem 1997;272:15036-15042.
4. Imai Y, Chantry D, Raport CJ, Wood CL, Nishimura M, Godiska R et al. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J Biol Chem 1998;273: 1764-1768.
5. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998;187:129-134.
6. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998;187: 875-883.
7. Sekiya T, Miyamasu M, Imanishi M, Yamada H, Nakajima T, Yamaguchi M et al. Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells. J Immunol 2000;165:2205-2213.
8. Terada N, Nomura T, Kin WJ, Otsuka Y, Takahashi R, Kishi H et al. Expression of C-C chemokine TARC in human nasal mucosa and its regulation by cytokines. Clin Exp Allergy 2001;31:1923-1931.
9. Shirakawa T, Deichmann K, Izuhara K, Mao I, Adra CN, Hopkin JM. Atopy and asthma: genetic variants of IL-4 and IL-13 signaling. Immunol Today 2000;21:160-164.
10. Kotsimbos TC, Ghaffar O, Minshall EM, Humbert M, Durham SR, Pfister R et al. Expression of the IL-4 receptor α-subunit is increased in bronchial biopsy specimens from atopic and non-atopic asthmatic subjects. J Alllergy Clin Immunol 1998;102:859-866.
11. National Institute of Health. National Asthma Education and Prevention Program: guideline for the diagnosis and management of asthma. NIH Publication, 1997; No. 97-4051.
12. Takishima T, Hida W, Sasaki H, Suzuki S, Sasaki T. Direct-writing recorder of the dose-response curves of the airway to methacholine. Chest 1981;80:600-606.
13. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, Macdonald S et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984;32:219-229.
14. Morita A, Kikuoka S, Horikawa T, Bito T, Yamada H, Kanda M et al. Evaluation of human thymus and activation-regulated chemokine concentrations in blood using a new sandwich ELISA based on monoclonal antibodies. Clin Chim Acta 2002;322:67-75.
15. Hoshino M, Takahashi M, Takai Y, Sim JJ. Inhaled corticosteroids decrease sub-epithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol 1999;104:356-363.
16. Sugawara N, Yamashita T, Ote Y, Miura M, Terada N, Kurosawa M. TARC in allergic disease. Allergy 2002;57:180-181.
17. Sekiya T, Yamada H, Yamaguchi M, Yamamotp K, Ishii A, Yoshie O et al. Increased levels of a TH2-type CC chemokine thymus and activation-regulated chemokine (TARC) in serum and induced sputum of asthmatics. Allergy 2002;57:173-177.
18. Leung TF, Wong CK, Lam CW, Li AM, Ip WK, Wong GWK et al. Plasma TARC concentration may be a useful marker for asthmatic exacerbation in children. Eur Respir J 2003;21:616-620.
19. Kakinuma Y, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with diseases activity. J Allergy Clin Immunol 2001;107:535-541.
20. Kawasaki S, Takizawa H, Yoneyama H, Nakayama T, Fujisawa R, Izumizaki M et al. Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice. J Immunol 2001;166:2055-2062.
21. Leung TF, Wong CK, Chan IHS, Mphil WKI, Lam CWK, Wong GWK. Plasma concentration of thymus and activation-regulated chemokine is elevated in childhood asthma. J Allergy Clin Immunol 2002;110:404-409.
22. Fujusawa T, Fujisawa R, Kato Y, Nakayama T, Morita A, Katsumata H et al. Presence of high contents of thymus and activation-regulated chemokine in platelets and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis. J Allergy Clin Immunol 2002;110:139-146.
23. Keegan AD, Nelms K, Wang LM, Pierce JH, Paul WE. Interleukin-4 receptor: signaling mechanism. Immunol Today 1994;15:423-432.
24. Bentley AM, Hamid Q, Robinson DS, Schotman E, Meng Q, Assoufi B et al. Prednisolone treatment in asthma: reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med 1996;153: 551-556.
25. Nasser T, Minshall EM, Leung DYM, Laberge S, Ernst P, Martin RI et al. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med 1997;155:845-851.
26. Hamilos DL, Thawley SE, Kramper MA, Kamil A, Hamid QA. Effect of intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression, and proinflammatory cytokine mRNA in nasal polyp disease. J Allergy Clin Immunol 1999;103: 79-87.
27. Matsukura S, Stellato C, Plitt JR, Bickel C, Miura K, Georas SN et al. Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells. J Immunol 1999;163:6876-6883.
28. Hart LA, Krishman VL, Adcock IM, Barnes PJ, Chung KF. Activation and localization of transcription factor, nuclear factor-κB, in asthma. Am J Respir Crit Care Med 1998;158:1585-1592.
29. Mullings RE, Wilson SJ, Puddicombe SM, Lordan JL, Bucchieri F, Djukanovic R et al. Signal transducer and activator of transcription 6 (STAT-6) expression and function in asthmatic bronchial epithelium. J Allergy Clin Immunol 2001;108:832-838.